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Signal-induced turnover of membrane phospholipids represents a fundamental transducing mechanism that 
induces a signal cascade resulting in mobilization of calcium, activation of protein kinase C by diacylglycer- 
01, release of arachidonic acid and stimulation of cyclic GMP production. In this pathway tumor-promoting 
phorbol esters such as phorbol myristate acetate (PMA) may substitute for diacylglycerol. The interferon- 
like antiviral effect of PMA described here suggests that the inositol phospholipid-diacylglycerol-protein 
kinase C sisal-tran~u~ng m~hanism may be involved in interferon action. 
Antiviral activity Phorbol ester Second messenger 
1. INTRODUCTION 
Interferons exert a wide range of effects on cells 
including establishment of an antiviral state, in- 
hibition of cell division, modulation of specialized 
cellular functions and modification of the cell sur- 
face [I]. In common with other biologically active 
substances the initial step in interferon (IFN) ac- 
tion is its binding to cell surface receptors [2]. It 
has been reported that following binding IFN ap- 
pears to be internalized; experimental data suggest, 
however, that internalization and degradation of 
IFNs are not responsible for their antiviral action 
131. This observation raises the possibility that IFN 
effects may be mediated by activation of in- 
tracellular messengers. 
Most tissues seem to possess only two major 
classes of receptors to control cellular functions. 
One class triggers the production of cyclic AMP, 
while the other initiates a cascade reaction 
resulting in the mobilization of Ca, activation of 
protein kinase C, release of arachidonic acid (for 
the synthesis of prostaglandins, thromboxanes and 
leukotrienes) and stimulation of guanilate cyclase 
to form cyclic GMP [4,5f. 
Both of these receptor-controlled systems are 
Interferon action Phosphatidylinositol turnover 
obvious candidates for the transmission of an IFN 
signal. Although CAMP is known to influence a 
number of processes affected by IFN [2], this 
system does not appear to be responsible for all 
IFN effects. 
It was reported recently that protein kinase C 
plays a very important role in signal transduction 
for a variety of biologically active substances [4]. 
When cells are stimulated protein kinase C is tran- 
siently activated by ~acylglycerol produced in the 
cell membrane during the signal-induced turnover 
of inositol phospholipids. In this respect tumor- 
promoting phorbol esters are able to substitute 
diacylglycerol and there is growing evidence that 
the cellular receptor for the phorbol ester is protein 
kinase C. 
We hypothesized that if IFN utilizes the inositol 
phospholipid-diacylglycerol-protein kinase C path- 
way then PMA should have an effect on cells 
similar to that of IFN. For this reason experiments 
were performed to determine whether PMA in- 
duces an interferon-like antiviral state of cells. 
2. MATERIALS AND METHODS 
2 mM PMA (4-phorbol 12-myristate 13-acetate, 
300 
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Sigma) in 0.2 ml portions was stored at - 20°C in 
dimethyl sulfoxide and diluted with medium 
before use. 
Hu-IFNa! was obtained from Klara odony (Egyt 
Pharmacochemical Works, Budapest). 
UAC cell line was obtained from Dr V. Sorren- 
tino (University of Rome, Italy). This is a human 
amniotic cell line widely used for IFN assay and 
known as a high producer of IFNP [6]. 
Vesicular stomatitis virus (VSV), Indiana strain, 
was used for challenge at a dose of 
50 TCD&lOO ~1. 
UAC cells were grown in Microtest TC plates 
(Falcon). Samples containing 1.5 x lo4 cells/well 
in Parker’s 199 medium with 2% fetal calf serum 
were incubated at 37°C in a 5% CO2 atmosphere 
before IFN and/or PMA treatment. 
Antiviral activity was tested by the cytopathic in- 
hibition method [7]. 
3. RESULTS AND DISCUSSION 
Table 1 shows the ~tic~opathic effect of both 
IFN and PMA. lo4 units of Hu-IFNa! totally in- 
hibited the cytopathic effect of VSV, and the same 
result was obtained with 20 nM PMA, a dose 
which is optimal for tumor promotion. It is worth 
mentioning that 1 nM PMA also proved to have 
some anticytopathic effect and that the presence of 
PMA during VSV infection was not necessary for 
the antiviral effect; a 3 h pretreatment of cells with 
Table 1 
Anticytopathic effect of different doses of Hu-IFNa and 
PMA 
Treatment of UAC cells Induced resistance 
before virus challenge by to VSV infection” 
None 
1 nM PMA + 
5 nM PMA if 
20 nM PMA +++ 
200 IU IFN ++ 
10000 IU IFN +++ 
1 nM PMA f 200 IU IFN +++ 
5 nM PMA f 200 IU IFN +++ 
a (+ + +) Total inhibition, (+ +) 50% inhibition, (+) 
lo-25% inhibition, f-) no inhibition, of the 
cytopathic effect 
PMA 1 day before virus infection resulted in a 
similar antic~opathic effect. 
Table 1 also shows that after giving suboptimal 
doses of IFN and PMA simultaneously, a 
synergistic effect could be observed. 
As PMA treatment proved to have a per se effect 
on cell morphology (some cells became spherical), 
in further experiments antic~opathic effect of 
PMA was expressed in such a way that PMA- 
treated but not virus-infected cells were used as 
controls. The data are shown in fig.1. It can be 
seen that 20 nM PMA proved to be an optimal 
dose; higher doses are less effective presumably as 
a consequence of their toxic effect. 
The anticytopathic effect of PMA observed pro- 
ves its potent in vitro antiviral activity. 
Referring to the mechanism of the antiviral ac- 
tion of phorbol esters, at least 4 different 
possibilities arise: (i) PMA has some kind of direct 
antimetabolic effect on virus synthesis, (ii) phorbol 
esters act as IFN inducers, (iii) the effect is due to 
changed virus adsorption, (iv) it acts through the 
activation of protein kinase C. 
(i) Although phorbol esters are not metabolic in- 
hibitors, in a cloned macrophage-like cell line 
PMA-induced resistance to VSV has been de- 
scribed [8]. Here it was concluded that part of this 
\ 
” 
/ 
Virus mfecfed cells treated with 
dlfferenf doses of PMA 
Fig. 1. Antic~opathi~ effect of different doses of PMA. 
PMA-treated cells were used as controls in the 
cytopathic inhibition assay described in section 2. 
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resistance was due to the H202 induced. In our 
case this mechanism is unlikely, since UAC cells 
did not produce Hz02 as a result of PMA treat- 
ment. (ii) IFN induction can be also rejected as a 
possibility, as a very short PMA treatment 
(15 min) before viral infection proved to be 
satisfactory in producing an antiviral effect; IFN 
induction and production are known to require a 
much longer period. It is worth mentioning that 
tumor-promoting phorbol esters have been 
reported to act as enhancers or inhibitors of IFN 
induction, but no IFN-inducing capacity has been 
observed [9,10]. (iii) The fact that PMA added to 
the cells 30 min after virus infection also proved to 
be potent in the cytopathic inhibition assay ex- 
cludes the putative role of altered virus infection in 
the phenomenon observed. (iv) The PMA-induced 
antiviral state of cells strongly supports our 
hypothesis, according to which IFN also acts 
through the inositol phospholipid-diacylglycerol- 
protein kinase C pathway. 
The antiviral effect of PMA described is not the 
only one suggesting its interferon-like properties. 
PMA and other biologically active phorbol esters 
have a variety of effects - including stimulation of 
synthesis of macromolecules, modulation of the 
metabolism of polyamines and cyclic nucleotides, 
stimulation of prostaglandin synthesis - similar to 
those of IFNs [l 11. There are also reports of im- 
munomodulatory effects of PMA [12,13]. There 
is, however, one important difference between the 
effects of the two substances: phorbol esters 
stimulate cell proliferation whereas IFNs generally 
do not. This discrepancy appears to be due to the 
ability of IFNs to induce the CAMP signal- 
transducing system which acts negatively and may 
block other positive signals [4]. Our experimental 
results are thus consistent with reported data and 
support the idea that the inositol phospholipid- 
diacylglycerol signal-transducing pathway is also 
involved in IFN action. 
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